Our understanding of the role of synonymous variants in cancer is rapidly expanding, with recent studies demonstrating that they may act as drivers of the disease [67–69], altering the function of oncogenes such as RET [70] and KRAS[71]. The gene discussed is KRAS; the disease is cancer.